Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF692 divergent transcript (ZNF692-DT) is a long non-coding RNA gene located near the protein-coding ZNF692 locus. According to HUGO and GeneCards, ZNF692-DT falls in the lncRNA gene class and appears within 300–500 nucleotides of a protein-coding gene, which is a standard feature for divergent transcripts. There is no published evidence suggesting functionality, disease relevance, or therapeutic targeting for ZNF692-DT. By contrast, ZNF692 (the protein-coding gene) encodes a Krüppel C2H2-type zinc finger transcription factor involved in cancer biology, but this is distinct from the ZNF692-DT lncRNA. If you are looking for a molecule with disease role, drug interaction, or a classic target profile, ZNF692-DT (ZNF692 divergent transcript) does not fulfill those criteria. Structured information about drug interactions, biomarkers, and disease roles applies only to the protein-coding gene ZNF692, NOT to ZNF692-DT.
None—no drugs have been shown to directly target ZNF692-DT.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF692 divergent transcript (ZNF692-DT).